Drugmaker AstraZeneca is asking the U.S. Food and Drug Administration to approve its FluMist influenza vaccine for self-use. If approved, the nasal spray would be the first flu vaccine approved for at-home use. It could be available in time for next fall’s flu season. The vaccine currently must be administered by a health care provider.
Source link